Covid-19 Update

Graham Brady Excerpts

Monday 21st September 2020 Commons Chamber

[Matt Hancock]

Vitamin D is one of the many things that we have looked into, to see whether it reduces the incidence or impact of coronavirus. I have seen reports that it does, so we put it into a trial. Unfortunately, the results were that it does not appear to have any impact. That is the latest clinical advice, which is always kept under review.

[Sir Graham Brady (Altrincham and Sale West) (Con)]

Does my right hon. Friend agree that balancing the measures to tackle covid with the other health consequences, such as cancer patients going undiagnosed or not being treated in time, and the economic and social consequences is a political judgment, and does he further agree that political judgments are improved by debate and scrutiny?

[Matt Hancock]

Yes, I do. I come to this Dispatch Box as often as possible. I am very sorry that I was unable to come on Friday to discuss Friday’s decision, but the House was not sitting. I agree with my hon. Friend that, essentially, the more scrutiny, the better; that is my attitude. I am very happy to continue to work with him and with you, Mr Speaker, to ensure that that scrutiny can be done at the speed that is sometimes required for these decisions to be made.

Finally, on my hon. Friend’s substantive point, of course minimising the impact on the economy and on education is critical, but there are impacts on the NHS of covid cases going up—not just the need to try to minimise the negative impact that comes from restricting other treatments, such as cancer, that happened in the first peak, but the problem of the NHS operating with high levels of covid cases. Within the NHS, a higher number of cases itself has an impact on the care available for all the other conditions that we need to treat, but I look forward to working with you, Mr Speaker, to make sure that we have continued scrutiny.